Speaker:
Dr. Athanasios Zouzos, Uppsala/SE

Description:
Digital Breast Tomosynthesis (DBT) is widely used for breast cancer screening in the USA, typically with single reading. In many European countries, double reading is standard, raising the question of whether artificial intelligence (AI) can replace one of the human readers. A pioneering team in Uppsala, Sweden, has successfully integrated 3D AI into their routine workflow and will share their experiences during this hands-on workshop. Participants will have the opportunity to review a variety of clinical cases demonstrating the use of 3D AI as a second reader for DBT screening in a clinical setting. The course facilitator will share insights from daily practice with AI-supported screening, and attendees will benefit from interactive discussions in a collaborative learning environment.

Learning objectives:
1. Understand how 3D AI technology (GAID) integrates with digital breast tomosynthesis (DBT) to enhance screening and reduce workload.
2. Recognize the learning curve and practical steps required to adopt 3D AI as a second reader in breast cancer screening.
3. Acquire knowledge useful for developing an implementation plan to introduce 3D AI technology in your clinical practice.

Speaker biography:
Dr. Athanasios Zouzos, MD, PhD, is a renowned breast radiologist and interventionist, currently serving as an associated researcher at the prestigious Karolinska Institute in Stockholm. He is also affiliated with Akademiska University in Uppsala (Evidia), where he contributes his expertise in advanced breast imaging and minimally invasive interventions. Dr. Zouzos is widely recognized for his commitment to education, research, and clinical excellence, making him a leading figure in the field of breast radiology and a sought-after facilitator for international hands-on educational events.

Time slots:

Thursday, October 1 | 17:30-18:30
Friday, October 2 | 13:00 – 14:00 
Saturday, October 3 |  09:00 – 10:00

Speaker:
Dr. Rubén Giovanetti González, Toledo/ES

Description:
This hands-on workshop, led by a breast imaging specialist from Toledo, Spain, will explore the application of AI-based breast cancer detection and workflow tools for 3D mammography (DBT). Participants will acquire knowledge through interactive sessions, as the teacher shares personal experience and guides attendees through interesting real-world cases on high-end mammography workstations. The workshop will emphasize discussion and active participation, allowing attendees to ask questions and engage directly with challenging clinical scenarios.

Learning objectives:
1. Explore the latest advancements in AI technology for 3D mammography through practical, hands-on case review.
2. Understand the specific challenges and opportunities of applying AI in 3D mammography (DBT) using real clinical scenarios.
3. Develop skills to evaluate, select, and integrate AI solutions for DBT in clinical practice, with direct experience on high-resolution mammography workstations.

Speaker biography:
Dr. Rubén Giovanetti González is a breast imaging specialist at Complejo Hospitalario de Toledo, Spain. He leads clinical research in AI-driven 3D mammography and microwave imaging, advancing early breast cancer detection. With extensive experience in multicenter trials and hands-on training, Dr. Giovanetti is committed to integrating innovative technologies in clinical practice and sharing his expertise with fellow professionals.

Time slot:
Thursday, October 1 | 13:00 – 14:00 

Speaker:
Dr. Adnan Duhovic, Vienna/Austria

Description:
DBT was first introduced into the Austrian Screening Program 01.2023. This interactive course looks at the learnings and best use of DBT in a nationwide screening program. This hands-on workshop offers a focused introduction to 3DQuorum technology, with practical implementation strategies drawn from real clinical experience. Participants will work through a variety of clinical cases, each demonstrating how Digital Breast Tomosynthesis (DBT) is used in everyday practice and processed with 3DQuorum. Through guided case reviews, you’ll develop a clear understanding of the technology and its clinical applications, along with practical tips for integrating it into your own workflow. The session is designed to encourage discussion, questions, and the sharing of insights among participants and the facilitator. Join us to deepen your knowledge of 3DQuorum and explore its potential to enhance breast imaging in clinical practice.

Learning objectives:
1. Gain a comprehensive understanding of 3DQuorum imaging technology, which aims to reduce workload while maintaining diagnostic accuracy
2. Be able to see enhancements in efficiency along the screening pathway
3. Comprehend the learning curve associated with adopting this new technology in medical imaging
4. Be able to create a plan for implementation at your own clinical site

Speaker biography: 
Dr. Adnan Duhovic is a distinguished radiologist specializing in mammography and breast health, based in Vienna, Austria.Dr. Duhovic underwent extensive radiology and nuclear medicine training at the Medical University of Vienna. He has held key roles, including specialist in radiology at Klinik Hietzing and independent practitioner at Diagnosezentrum Liesing and Röntgen Goldenes Kreuz. Since January 2023, he has been a pivotal member of Wiener Radiologie and Röntgen Goldenes Kreuz, focusing on mammography and breast health. At the Breast Health Center at Privatklinik Goldenes Kreuz, Dr. Duhovic leads efforts in early breast cancer detection and diagnosis, performing mammography and breast ultrasound screenings. He collaborates within an interdisciplinary tumor board to ensure comprehensive, personalized care for patients. Additionally, Dr. Duhovic is a lecturer at FH Campus Wien. His commitment to patient care and interdisciplinary collaboration significantly impacts breast health diagnostics and treatment in Vienna and beyond.

Time slots:
Thursday, October 1 | 15:00 – 16:00
Friday, October 2 | 08:30 – 09:30
Saturday, October 3 | 14:00 – 15:00

Speakers:
Dr. Jacopo Nori Cucchiari, Dr. Chiara Bellini, Dr. Francesca Pugliese, Dr. Verdiana Lamagna, Florence/IT

Description:
In this interactive, hands-on workshop, participants will build practical, end-to-end proficiency in daily CEM practice — from acquisition through reporting. Guided by experienced breast radiologists, attendees will review recommended CEM protocols and learn to recognize and manage common artefacts that can affect image quality and interpretation. The session will then focus on applying the standardized CEM lexicon during real-time reporting, helping participants identify key imaging features that differentiate benign from malignant lesions and distinguish normal from abnormal enhancement patterns. Through hands-on case review and collaborative discussion, attendees will gain confidence selecting appropriate descriptors and producing clear, consistent reports that support referring clinicians. This practical, case-based approach ensures participants leave equipped to apply protocols, lexicon, and quality control together in routine clinical workflow.

Learning objectives:
1. Master standardized CEM acquisition protocols to ensure consistent, high-quality imaging in daily practice.
2. Apply the standardized CEM lexicon accurately and confidently during real-time reporting of clinical cases.
3. Recognize and manage common CEM artefacts to avoid misinterpretation and maintain diagnostic accuracy.

Speakers biography:
Dr. Jacopo Nori Cucchiari is a consultant breast radiologist and the Chief of Breast Imaging at Careggi University Hospital in Florence, Italy. He has completed attachments at the Institute Gustave Roussy in Paris, Montpellier University Hospital in France and the Memorial Sloan Kettering Cancer Center in New York. In addition to breast tomosynthesis and tomo guided biopsies , magnetic resonance imaging and contrast enhanced breast imaging.
In the last two years he has implemented MRI and CEM guide biopsy procedures. Dr Nori’s interests also include cryoablation , radiofrequency and laser ablation of breast lesions and B3 lesion removal with VABB systems (VAE) .
He is an author and co-author of numerous abstracts and publications in national and international journals, as well as two imaging books – one on interventional radiology procedures in senology and the other on mammography of ductogalactographic investigation in senology , and two books about contrast enhanced mammography. 

Dr. Chiara Bellini is a breast radiologist at the University Hospital AOU Careggi in Florence, Italy. An active researcher since 2015, she specialises in multimodality breast radiology, particularly Contrast-Enhanced Mammography (CEM) and Breast Interventional Radiology. Dr. Bellini frequently speaks at conferences in Italy and Europe, focusing on CEM. She has authored several papers, three book chapters on CEM, numerous scientific posters, and presentations.

Dr. Francesca Pugliese is a radiology resident at the University Hospital AOU Careggi in Florence, Italy, where she specializes in the breast imaging unit. An active researcher since she began her residency in 2021, Dr. Pugliese is highly skilled in advanced breast imaging techniques, including Contrast-Enhanced Mammography (CEM), MRI, mammography, and ultrasound. Her expertise also extends to performing interventional procedures, such as biopsies. She is an active member of the scientific community, having presented her findings at the European Congress of Radiology and co-authored several papers.

Verdiana Lamagna is a Radiology resident at Careggi University hospital of Florence, specializing in breast imaging. Her interest in breast diagnostics developed during medical school in Florence and continues to drive her professional growth. She is currently training in both diagnostic and interventional breast radiology, with a particular focus on contrast-guided biopsy techniques and percutaneous treatment procedures such as cryoablation.

Time slot:
Friday, October 2 | 10:30 – 11:30

Speakers:
Dr. Jacopo Nori Cucchiari, Dr. Chiara Bellini, Dr. Francesca Pugliese, Dr. Verdiana Lamagna, Florence/IT

Description:
This hands-on workshop explores the expanding clinical applications of contrast-enhanced mammography (CEM) across the patient care pathway. Participants will first master the use of CEM for tumor delineation and staging, strengthening their ability to support accurate presurgical planning and pre-treatment decision-making. Through practical exercises and real-case scenarios, attendees will learn to perform comprehensive CEM assessments that inform surgical approach and monitor treatment response. The session will then turn to a growing area of interest: using CEM to manage patients with a personal history of breast cancer (PHBC). Participants will review current evidence on CEM’s sensitivity and specificity in detecting recurrence, gain hands-on experience distinguishing post-treatment changes from recurrent disease, and learn best practices for integrating CEM findings into multidisciplinary, risk-adapted follow-up planning.

Learning objectives:
1. Master the role of CEM in tumor delineation, staging, and presurgical planning for breast cancer.
2. Apply CEM findings to support pre-treatment planning and monitor treatment response over time.
3. Understand current research and clinical evidence on using CEM to manage patients with a personal history of breast cancer (PHBC).
4. Develop practical skills in interpreting CEM images to distinguish post-treatment changes from recurrent disease, and integrate findings into multidisciplinary patient management.

Speakers biography:
Dr. Jacopo Nori Cucchiari is a consultant breast radiologist and the Chief of Breast Imaging at Careggi University Hospital in Florence, Italy. He has completed attachments at the Institute Gustave Roussy in Paris, Montpellier University Hospital in France and the Memorial Sloan Kettering Cancer Center in New York. In addition to breast tomosynthesis and tomo guided biopsies , magnetic resonance imaging and contrast enhanced breast imaging.
In the last two years he has implemented MRI and CEM guide biopsy procedures. Dr Nori’s interests also include cryoablation , radiofrequency and laser ablation of breast lesions and B3 lesion removal with VABB systems (VAE) .
He is an author and co-author of numerous abstracts and publications in national and international journals, as well as two imaging books – one on interventional radiology procedures in senology and the other on mammography of ductogalactographic investigation in senology , and two books about contrast enhanced mammography.

Dr. Chiara Bellini is a breast radiologist at the University Hospital AOU Careggi in Florence, Italy. An active researcher since 2015, she specialises in multimodality breast radiology, particularly Contrast-Enhanced Mammography (CEM) and Breast Interventional Radiology. Dr. Bellini frequently speaks at conferences in Italy and Europe, focusing on CEM. She has authored several papers, three book chapters on CEM, numerous scientific posters, and presentations.

Dr. Francesca Pugliese is a radiology resident at the University Hospital AOU Careggi in Florence, Italy, where she specializes in the breast imaging unit. An active researcher since she began her residency in 2021, Dr. Pugliese is highly skilled in advanced breast imaging techniques, including Contrast-Enhanced Mammography (CEM), MRI, mammography, and ultrasound. Her expertise also extends to performing interventional procedures, such as biopsies. She is an active member of the scientific community, having presented her findings at the European Congress of Radiology and co-authored several papers.

Verdiana Lamagna is a Radiology resident at Careggi University hospital of Florence, specializing in breast imaging. Her interest in breast diagnostics developed during medical school in Florence and continues to drive her professional growth. She is currently training in both diagnostic and interventional breast radiology, with a particular focus on contrast-guided biopsy techniques and percutaneous treatment procedures such as cryoablation.

Time slot:
Friday, October 2 | 16:00-17:00

Speakers:
Dr. Jacopo Nori Cucchiari, Dr. Chiara Bellini, Dr. Francesca Pugliese, Dr. Verdiana Lamagna, Florence/IT

Description:
In this hands-on workshop, participants will learn how contrast-enhanced mammography (CEM) supports diagnostic accuracy and decision-making across interventional breast procedures, with a particular focus on CEM-guided biopsy. The session opens with CEM as a problem-solving tool in complex or indeterminate scenarios, particularly in patients with dense breast tissue or ambiguous conventional imaging findings. Participants will develop practical skills in guiding biopsy with precision, and discuss CEM’s value as a faster, more patient-friendly alternative to MRI-guided biopsy — reducing procedure time and improving patient comfort without compromising diagnostic accuracy. Building on this foundation, the workshop introduces CEM’s emerging role in cryoablation surveillance, drawing on real clinical experience from an active cryoablation program, where case-based discussion will show how CEM is used to detect residual or recurrent disease following minimally invasive therapy. Attendees will leave with practical strategies for integrating CEM into interventional workflows and multidisciplinary patient management.

Learning objectives:
1. Develop practical skills in using CEM to guide biopsy procedures in complex clinical scenarios.
2. Strengthen diagnostic problem-solving strategies using CEM as a complementary imaging tool in interventional workflows.
3. Understand the application of CEM in monitoring and surveillance following cryoablation treatment.
4. Integrate CEM-guided interventional findings into comprehensive, multidisciplinary patient management plans.

Speakers biography:
Dr. Jacopo Nori Cucchiari is a consultant breast radiologist and the Chief of Breast Imaging at Careggi University Hospital in Florence, Italy. He has completed attachments at the Institute Gustave Roussy in Paris, Montpellier University Hospital in France and the Memorial Sloan Kettering Cancer Center in New York. In addition to breast tomosynthesis and tomo guided biopsies , magnetic resonance imaging and contrast enhanced breast imaging.
In the last two years he has implemented MRI and CEM guide biopsy procedures. Dr Nori’s interests also include cryoablation , radiofrequency and laser ablation of breast lesions and B3 lesion removal with VABB systems (VAE) .
He is an author and co-author of numerous abstracts and publications in national and international journals, as well as two imaging books – one on interventional radiology procedures in senology and the other on mammography of ductogalactographic investigation in senology , and two books about contrast enhanced mammography.

Dr. Chiara Bellini is a breast radiologist at the University Hospital AOU Careggi in Florence, Italy. An active researcher since 2015, she specialises in multimodality breast radiology, particularly Contrast-Enhanced Mammography (CEM) and Breast Interventional Radiology. Dr. Bellini frequently speaks at conferences in Italy and Europe, focusing on CEM. She has authored several papers, three book chapters on CEM, numerous scientific posters, and presentations.

Dr. Francesca Pugliese is a radiology resident at the University Hospital AOU Careggi in Florence, Italy, where she specializes in the breast imaging unit. An active researcher since she began her residency in 2021, Dr. Pugliese is highly skilled in advanced breast imaging techniques, including Contrast-Enhanced Mammography (CEM), MRI, mammography, and ultrasound. Her expertise also extends to performing interventional procedures, such as biopsies. She is an active member of the scientific community, having presented her findings at the European Congress of Radiology and co-authored several papers.

Verdiana Lamagna is a Radiology resident at Careggi University hospital of Florence, specializing in breast imaging. Her interest in breast diagnostics developed during medical school in Florence and continues to drive her professional growth. She is currently training in both diagnostic and interventional breast radiology, with a particular focus on contrast-guided biopsy techniques and percutaneous treatment procedures such as cryoablation.

Time slot:
Saturday,  October 3 |  11:00 – 12:00 

Speaker:
​Dr. Marc Lobbes, Sittard, Netherlands

Description:
This interactive, small-group workshop is designed to strengthen participants’ practical understanding of vacuum-assisted breast biopsy using both Contrast Enhanced Mammography-guided and Digital Breast Tomosynthesis-guided approaches.
The session combines a focused educational introduction with hands-on training using a live system. Participants will explore key workflow considerations, practical biopsy techniques, and the use of real-time specimen imaging integrated into the biopsy device. With attendance limited to a small group, the workshop is structured to maximize hands-on time, interaction with the course facilitator, and access to the equipment. Participants will have ample opportunity to practice, ask questions, and discuss practical considerations relevant to image-guided breast biopsy workflows.

Learning objectives:
1. Acquire a solid understanding of the principles and workflow of CEM-guided and DBT-guided vacuum-assisted breast biopsy.
2. Develop an understanding of the clinical applications, available technologies, and practical workflow considerations for image-guided breast biopsy.
3. Gain practical hands-on familiarity with CEM-guided, DBT-guided, and real-time specimen imaging workflows, supporting their integration into clinical practice.

Speaker biography:
Dr. Marc Lobbes, MD, PhD, is a Dutch breast radiologist with extensive expertise in breast imaging, image-guided interventions, and multidisciplinary breast cancer care. His clinical work spans mammography, breast ultrasound, MRI, and minimally invasive biopsy and localization procedures. Alongside his high-volume clinical practice, Professor Lobbes is actively involved in research, education, and professional initiatives aimed at advancing breast imaging standards and improving diagnostic accuracy. He has contributed to clinical studies, peer-reviewed publications, and national and international teaching activities. With a strong focus on evidence-based practice, multidisciplinary collaboration, and patient-centered communication, he continues to support high-quality breast cancer diagnostics and care.

Time slots:

Thursday, October 1 |15:30-16:15
Friday, October 2 | 10:30-11:15
Friday, October 2 | 15:00-15:45
Saturday, October 3 | 16:00-16:45

Speaker:
Dr. Simon Lowes, Gateshead/UK

Description:
This 30-minute workshop reviews wire and wire-free localisation for breast lesion identification. It covers the underlying principles, the role of ultrasound and stereotactic guidance, and the comparative evidence on accuracy, safety and workflow. Participants then spend a substantial part of the session hands-on at phantom stations, working with fully functional localisation equipment to place and detect markers under imaging guidance, with time at the equipment for every attendee. Delegates leave able to weigh the practical advantages and limitations of each approach, including implications for scheduling, theatre logistics and the multidisciplinary team.

Learning objectives:
1. Understand the Principles: Gain an understanding of wire and wire-free localisation techniques.
2. Review Imaging Guidance: Learn the roles of ultrasound and stereotactic guidance in both techniques.
3. Evaluate Advantages and Limitations: Compare the key advantages and limitations of wire and wire-free localisation methods.

Speaker biography:
Dr. Simon Lowes is a consultant breast radiologist and clinical lead for breast imaging at Gateshead Health NHS Foundation Trust. He is also Director of the Northern Centre for Breast Research and Honorary Clinical Senior Lecturer at Newcastle University. With qualifications including BSc (Hons), MB BS (Hons), MA, PhD, and FRCR, he specializes ultrasound-guided breast interventions, and innovative imaging techniques. Dr Lowes is Treasurer of the British Society of Breast Radiology and is the current Royal College of Radiologists’ Roentgen Professor. He is a published researcher and associate editor for Clinical Radiology and the British Journal of Radiology, actively contributing to clinical, educational, and strategic advances in breast radiology.

Time slots:

Thursday, October 1 | 13:30-14:00
Friday, October 2 | 12:00-12:30
Saturday, October 3 | 08:30-09:00
Saturday, October 3 | 15:00-15:30

Speaker:
Dr. med. Christoph Uleer, Hildesheim/DE

Description:
Enhance your skills in ultrasound-guided marker placement through this highly practical, hands-on workshop. Guided by an experienced breast imaging expert, participants will practice key techniques, discuss clinical cases, and explore evidence-based approaches to achieving accurate and reproducible results. Designed to foster both skill development and professional exchange, the workshop provides ample opportunity for interactive discussion, peer learning, and direct feedback from the trainer. Participants will benefit from practical tips, clinical insights, and real-world experience that go beyond standard procedural training. Participants will leave with enhanced procedural skills, increased confidence, and practical strategies to support high-quality patient care in their daily clinical practice.

Learning objectives:
1. Understand the Technique
2. Develop Practical Skills
3. Evaluate Patient Safety and Comfort

Speaker biography:
Dr. Christoph Uleer is a distinguished gynaecologist specializing in breast cancer screening and diagnostics. Actively involved in mammogram reading since 2006, he has been co-leading the regional breast cancer screening unit in South Lower Saxony with radiologist Thomas Werner since 2014. Dr. Uleer is an investigator in the DIMASOS-trial, which examines the efficacy of additional sonography for dense breasts within the Mammography Screening Program. He performs approximately 500 US-guided biopsies annually, expertly marking lesions with titanium clips. His contributions to early breast cancer detection and diagnosis have significantly advanced the field and improved patient outcomes.

Time slots:

Thursday, October 1 | 12:30 – 13:00
Friday, October 2 | 13:00 – 13:30
Saturday, October 3 | 10:30 – 11:00

Speaker:
Dr. David Evans, London/UK

Description:
This ultrasound guided breast biopsy workshop will allow participants to get hands-on experience with the ATEC vacuum biopsy unit. An experienced Consultant in interventional breast procedures will share theoretical and practical experience in an interactive hands-on environment. Small groups will ensure all participants get a personal hands-on experience at the stations. The workshop will use an engaging interactive approach and the latest technology to allow participants a unique, practical learning experience.

Learning objectives:
1. To review different biopsy indications with US guidance.
2. To understand and select the best technology for a specific clinical situation.
3. To learn tips & tricks for improving clinical confidence.
4. To get a good realistic hands-on experience with US guided vacuum biopsy.

Speaker biography:
Dr. Evans is Consultant Radiologist at St. Bartholomew’s Hospital, London, having over 20 years’ experience in breast imaging. His specialist interest is breast intervention and has been undertaking vacuum assisted and other complex biopsy techniques since 2002, using ultrasound, mammographic and MRI guidance. He has been a member of the Education Faculty of both the UK Royal College of Radiologists and Royal College of Surgeons. He has led breast biopsy workshops at the European Congress of Radiology, UK Radiological Congress, Symposium Mammographicum and the Gulf Radiological Congress. He is author of the breast biopsy chapter of the Cambridge University press textbook ‘Breast Cancer’.

Time slots:

Thursday, October 1 | 16:30 – 17:00
Friday, October 2 | 08:30 – 09:00
Friday, October 2 | 17:00-17:30
Saturday, October 3 | 09:30 – 10:00

Speakers:
Dr. Andreas Karakatsanis, Uppsala/SE
Dr. Athanasios Zouzos, Uppsala/SE

Description:
Wire-guided localisation ties an entire breast unit to a single morning: radiology places the wire, theatre waits, and any complication reshapes the day. A randomised trial of 426 patients has since shown that combining a paramagnetic seed with a magnetic lymphatic tracer performs comparably to guidewire localisation, with fewer failed localisations and shorter operative times. In this Meet the Expert session, a breast surgeon and a breast radiologist share their experience of putting that approach into practice. They describe how the technique was introduced, what it asked of each specialty, and how separating localisation from the day of surgery changed planning on both sides — followed by open discussion with the audience.

Learning objectives:
1. Understand the rationale for moving from wire- and isotope-based methods to a wire-free, isotope-free pathway for lesion localisation and sentinel node detection.
2. Discuss how decoupling localisation from the day of surgery redistributes tasks, timing and responsibilities between radiologist and surgeon, and what each specialty gains in planning autonomy.
3. Apply these learnings to your own setting, considering the practical steps, learning curve and workflow implications of adopting the technique locally.

Speakers biography:
Andreas Karakatsanis, MD, PhD, FEBS, is Chief of Breast Surgery at Akademiska University Hospital and Associate Professor of Breast Surgery at Uppsala University, Sweden. Originally from Greece, he has built his surgical and academic career in Uppsala, where he directs the international oncoplastic breast surgery fellowship and founded the Uppsala Breast Meeting. His research centres on minimally invasive breast cancer surgery, sentinel node biopsy and magnetic localisation techniques, including the MAGTOTAL and SentiNot trials, alongside the health-economic and logistical dimensions of breast cancer care. He was senior author of the randomised MAGTOTAL trial comparing magnetic seed and guidewire localisation, published in JAMA Surgery, and lectures widely at international breast surgery meetings.

Dr. Athanasios Zouzos, MD, PhD, is a renowned breast radiologist and interventionist, currently serving as an associated researcher at the prestigious Karolinska Institute in Stockholm. He is also affiliated with Akademiska University in Uppsala (Evidia), where he contributes his expertise in advanced breast imaging and minimally invasive interventions. Dr. Zouzos is widely recognized for his commitment to education, research, and clinical excellence, making him a leading figure in the field of breast radiology and a sought-after facilitator for international hands-on educational events.

Time slot:
Saturday, October 3 | 13:30 – 14:00 

Speaker:
Prof. Ruud Pijnappel, Utrecht/NL

Description:
This session traces the full arc of a population-based breast-screening program — from the first sketch, where public health priorities and epidemiological data shape initial plans, through to implementation and ongoing evaluation. It opens with the building blocks: program structure, the invitation of women, and the data infrastructure that holds it all together. The discussion then turns to the evidence on the benefits and potential harms of screening, and to the needs of the individual within a population framework. It closes on the practical question every organizer faces: how to design a program that fits your own population, diagnostic capabilities, and therapeutic infrastructure — aligning evidence-based practice with local realities to ensure both equity and efficacy.

Learning objectives:
1. To get familiar with the set-up of a program, invitation of women and data infrastructure
2. To learn about the benefits and harms of breast cancer screening
3. To learn about the specific needs for individuals in a framework of population-based screening
4. To know how to organize screening fitted to your population, your diagnostic capabilities and therapeutic infrastructure

Speaker biography:
Prof. Ruud Pijnappel studied Medicine at the University of Amsterdam. He did his residency in Radiology with the OLVG, Amsterdam. After finalising his PhD thesis on the diagnosis of nonpalpable breast lesions (2002, Utrecht), he held several positions with the Breast Radiology department of the Martini hospital (Groningen) and the Dutch Reference Centre for Screening (LCRB, Nijmegen). From 2011 to 2015 he was president of the Dutch College of Breast Imaging (DCBI). In 2012 he joined the Radiology staff of the UMC Utrecht; in 2015 he was appointed both Professor of Breast Radiology at the UMC Utrecht, and CEO of the Dutch Expert Centre for Screening. He currently holds the position as immediate past-president of the European Society of Breast Imaging (EUSOBI).

Time slot:
Friday, October 2 |  16:00 – 17:00

Speaker:
Prof. Ruud Pijnappel, Utrecht/NL

Description:
This session will highlight the importance of a short time-interval between a recall from screening and a final diagnosis. In screening assessment follow-up strategies must be avoided to minimize the uncertainty and fear for women about the real nature of the screen-detected abnormality. The successful operation of a breast-screening program depends not only on sound planning but also on the integration of diagnostic pathways that swiftly and accurately address positive findings. Once a screening program is underway, attention must turn to the critical phase where lesions are detected and require further assessment. This transition from population-level screening to individualized diagnostic workup demands clear protocols, multidisciplinary coordination, and timeliness to minimize anxiety and optimize outcomes for participants. Navigating this phase involves balancing sensitivity with specificity, ensuring that unnecessary interventions are avoided while prompt care is provided to those at genuine risk. The adoption of standardized reporting systems, such as BIRADS, assists clinicians in categorizing findings and communicating risk, yet also introduces challenges in interpretation and follow-up strategies. The effectiveness of the overall program hinges on how efficiently and reliably these screen-detected abnormalities are triaged, diagnosed, and managed—closing the loop between early detection and definitive care. BIRADS 3 as outcome of a screening assessment is undesirable from a patient’s perspective, costly and inefficient. The management of calcifications will be discussed in depth.

Learning objectives:
1. To get familiar with the transition from a screening to a clinical BIRADS classification.
2. To learn about the impact of time between screening and final diagnosis on re-attendance.
3. To know the importance of avoiding BIRADS 3 as ‘final diagnosis’
4. The impossibility of judging the true nature of an underlying disease accompanied by calcifications by judging it on only visual on mammography.

Speaker biography:
Prof. Ruud Pijnappel studied Medicine at the University of Amsterdam. He did his residency in Radiology with the OLVG, Amsterdam. After finalising his PhD thesis on the diagnosis of nonpalpable breast lesions (2002, Utrecht), he held several positions with the Breast Radiology department of the Martini hospital (Groningen) and the Dutch Reference Centre for Screening (LCRB, Nijmegen). From 2011 to 2015 he was president of the Dutch College of Breast Imaging (DCBI). In 2012 he joined the Radiology staff of the UMC Utrecht; in 2015 he was appointed both Professor of Breast Radiology at the UMC Utrecht, and CEO of the Dutch Expert Centre for Screening. He currently holds the position as immediate past-president of the European Society of Breast Imaging (EUSOBI).

Time slot:
Saturday, October 3 | 12:30 – 13:00

Speaker:
Dr. Marc Lobbes, Sittard/NL

Description:
When can you stop sampling? It’s one of the most practical questions in CEM-guided biopsy — and one of the least standardized. In this Meet the Expert session, [Speaker name] shares first-hand experience from a study examining the relationship between the number of samples taken during CEM-guided biopsy and the definitive histopathological result. The discussion covers real-world decision-making, balancing diagnostic certainty against procedure time and patient comfort, and how sampling strategy fits into everyday workflow. The small-group format leaves ample room for an interactive Q&A — bring your own cases and questions to the discussion with the presenter.

Learning objectives:
1. Acquire a solid understanding of the relationship between core sample number and definitive diagnosis in CEM-guided biopsy.
2. Develop an understanding of the practical trade-offs involved in sampling decisions.
3. Gain insight from the presenter’s first-hand study experience, supporting a more consistent approach to CEM-guided biopsy sampling.

Speaker biography:
Dr. Marc Lobbes, MD, PhD, is a Dutch breast radiologist with extensive expertise in breast imaging, image-guided interventions, and multidisciplinary breast cancer care. His clinical work spans mammography, breast ultrasound, MRI, and minimally invasive biopsy and localization procedures. Alongside his high-volume clinical practice, Professor Lobbes is actively involved in research, education, and professional initiatives aimed at advancing breast imaging standards and improving diagnostic accuracy. He has contributed to clinical studies, peer-reviewed publications, and national and international teaching activities. With a strong focus on evidence-based practice, multidisciplinary collaboration, and patient-centered communication, he continues to support high-quality breast cancer diagnostics and care.

Time slot:
Friday, October 2 | 09:30 – 10:00

Speaker:
Dr. Nisha Sharma, Leeds/UK

Description:
How often does the first biopsy give the final answer? Dr Nisha Sharma presents the largest comparative evidence base to date on vacuum-assisted breast biopsy (VABB) versus core needle biopsy (CNB): a systematic review and meta-analysis of 60 studies and up to 35,500 patients, published in European Radiology. What does this mean for current guidelines and clinical pathways? The session covers ADH and DCIS underestimation, repeat biopsies and calcification retrieval, alongside an honest look at where the advantage narrows and what that means for your practice. Seats are limited, so every attendee has the chance to debate directly with Dr Sharma in the Q&A that follows.

Learning objectives:
1. Evaluate the diagnostic performance of VABB versus CNB across underestimation, repeat biopsy, concordance and calcification retrieval outcomes.
2. Apply the findings to first-line biopsy selection, distinguishing lesions where VABB adds most value from those where CNB remains appropriate.
3. Appraise the limitations of the evidence base, including study design, heterogeneity and the effect of matching imaging guidance.

Speaker biography:
Dr Nisha Sharma is the Director of the Breast Screening Programme for Leeds and Wakefield and a Consultant Breast Radiologist. She is the lead author and scientific guarantor of the systematic review and meta-analysis of vacuum-assisted breast biopsy versus core needle biopsy presented in this session, published in European Radiology in 2026. She is actively involved in research and audit and is recognised as a national and international speaker. Dr Sharma developed the UK breast screening guidelines for managing high-risk lesions and participates in several clinical trials aimed at minimising overtreatment and supporting risk-adapted screening. She is also engaged in studies involving artificial intelligence in breast imaging. Dr Sharma serves on multiple professional committees, is the audit lead for the British Society of Breast Radiology (BSBR) and plays a key role in the training of radiologists.

Time slot:
Friday, October 2 | 14:00-14:30

Speaker:
Cary van Landsveld-Verhoeven, Nijmegen/NL

Description:
Positioning is the foundation of every screening mammogram. When breast tissue is missed or overlapped, cancers can be hidden, and no amount of technology or expert reading can recover what was never captured. Drawing on decades of shaping the training of mammography technologists in the Dutch national screening program, the speaker connects the detail of daily positioning practice to the performance of an entire program. She shares how the training is structured, how quality is monitored and sustained over time, how to make feedback stick, and the practical lessons learned along the way. Participants will leave with a blueprint of concrete, adaptable approaches for strengthening positioning quality in their own screening programs.

Learning objectives:
1. To understand why positioning quality is critical in screening mammography, and how missed or overlapping breast tissue can conceal cancers
2. To learn how positioning quality is monitored and benchmarked within a national screening program, and how it influences detection, recall and overall program performance
3. To know how to build and sustain a structured positioning training program.

Speaker biography
Cary van Landsveld-Verhoeven is a leading international authority on mammographic positioning. For decades she shaped the training and quality assurance of the Netherlands’ screening radiographers as Senior Consultant Radiographer at the LRCB, the Dutch Expert Centre for Screening, a role she concluded in 2026. She initiated a European expert group of mammographers, and her work, reaching more than 550 screening radiographers nationally, spanned guideline development, auditing, and research into the link between positioning and image quality. She chaired the biennial Dutch symposium for breast radiographers, has published widely on positioning quality and training, and is the author of a book on mammographic positioning technique. She continues to teach and advise internationally.

Time slot:
Thursday, October 1 | 17:30-18:00